We have published a safe at work letter for people with rheumatic diseases who are located in England and are at higher risk from Covid-19...
Take action against ending free COVID-19 testing kits
Join us in calling on the UK Government to continue free tests for people who are eligible for COVID-19 treatments, their families and close contacts....
MELODY Study: An Overview
The MELODY (Mass evaluation of lateral flow immunoassays for the detection of SARS-CoV-2 antibody responses in immunosuppressed people) study will use home antibody testing to understand how well immunocompromised...
Online survey – Steroid PRO study
Are you being treated with steroids for your rheumatic condition? We need your help to test a new questionnaire about steroid impact on quality of...
Guidance on Covid-19 vaccination for the severely immunosuppressed
As the pandemic continues to develop and new variants emerge, we will be using this article to make sure everyone has access to important information...
New antibody treatments available for immunosuppressed patients
From the 16th December high risk patients (severely immunosuppressed) who have tested positive for COVID-19 and have onset of symptoms in the last 7 days...
Are you eligible for a third dose or a booster vaccine?
Third doses of the COVID-19 vaccine are being offered to severely immunosuppressed people, either because of a health condition or treatment. This is because research...
NHS online booking system updated to include third primary dose
We are pleased to see that NHS England have updated the COVID-19 vaccination booking system on their website to include a category for third primary...
Survey shows nearly a quarter of people with rheumatic conditions are struggling to get access to a vital third primary jab
RAIRDA and its member charities are calling for urgent government action to address concerns about the roll-out of third primary doses for the COVID-19 vaccine....
Charities launch rapid third primary vaccination dose survey
Along with a number of other charities, RAIRDA and its member charities are supporting a rapid survey aimed at all adults with a rheumatic condition in the UK. We...
Statement on third primary COVID-19 vaccine doses for people with rare autoimmune rheumatic diseases
Over the past few weeks, RAIRDA’s member charities have had hundreds of calls from patients reporting problems arranging the third primary COVID-19 vaccination dose they are...
RAIRDA calls for specialised centre within Wales
RAIRDA recently submitted evidence to the Welsh Government in response to their consultation on guidance for services for people with arthritis and long-term musculoskeletal conditions....
We use cookies to collect and analyse information on site performance and usage and to ensure that we give you the best experience on our website.Allow all cookiesRefuse cookies
You can revoke your consent any time using the revoke consent button.Revoke consent
